Straight From The Cutter's Mouth: A Retina Podcast podkast

Episode 505: SOL-1 Trial Result Discussion with Drs. Jeffrey Heier and Peter Kaiser

0:00
NaN:NaN:NaN
Do tyłu o 15 sekund
Do przodu o 15 sekund
Drs. Jeffrey Heier and Peter Kaiser of Ocular Therapeutix join to discuss the SOL-1 trial results investigating a novel tyrosine kinase inhibitor for wet age-related macular degeneration. Conflicts of Interest: Dr. Sridhar has consulted on an advisory board in the past 24 months for Ocular Therapeutix. Dr. Heier and Dr. Kaiser are employed by Ocular Therapeutix.

Więcej odcinków z kanału "Straight From The Cutter's Mouth: A Retina Podcast"